Elicio Therapeutics, Inc. (ELTX)
Elicio Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: $12.00 - $14.00
Current IPO price range
Total Valuation
ELTX has a market cap or net worth of $180.42 million. The enterprise value is $166.48 million.
Market Cap | 180.42M |
Enterprise Value | 166.48M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
ELTX has 13.88 million shares outstanding.
Shares Outstanding | 13.88M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | 3.98 |
Debt / Equity | 0.00 |
Debt / EBITDA | 0.00 |
Debt / FCF | 0.00 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$858,904 |
Employee Count | 22 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (1Y) | n/a |
Total Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Average Volume (30 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -18.90M |
Net Income | -18.90M |
EBITDA | -18.69M |
EBIT | -18.90M |
Earnings Per Share (EPS) | -$1.36 |
Balance Sheet
The company has $13.93 million in cash and no debt, giving a net cash position of $13.93 million or $1.00 per share.
Cash & Cash Equivalents | 13.93M |
Total Debt | 0 |
Net Cash | 13.93M |
Net Cash Per Share | $1.00 |
Book Value | -54.87M |
Book Value Per Share | -3.95 |
Working Capital | 11.51M |
Cash Flow
In the last 12 months, operating cash flow was -$20.27 million and capital expenditures -$210,982, giving a free cash flow of -$20.48 million.
Operating Cash Flow | -20.27M |
Capital Expenditures | -210,982 |
Free Cash Flow | -20.48M |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ELTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -10.47% |
FCF Yield | -11.35% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |